Free Trial

Exact Sciences (EXAS) Short Interest Ratio & Short Volume

Exact Sciences logo
$52.70 -1.22 (-2.26%)
(As of 11/20/2024 ET)

Exact Sciences Short Interest Data

Exact Sciences (EXAS) has a short interest of 14.06 million shares. This marks a -9.52% decrease in short interest from the previous month. The short interest ratio (days to cover) is 5.9, indicating that it would take 5.9 days of the average trading volume of 3.43 million shares to cover all short positions.

Current Short Interest
14,060,000 shares
Previous Short Interest
15,540,000 shares
Change Vs. Previous Month
-9.52%
Dollar Volume Sold Short
$969.16 million
Short Interest Ratio
5.9 Days to Cover
Last Record Date
October 31, 2024
Outstanding Shares
185,080,000 shares
Percentage of Shares Shorted
7.60%
Today's Trading Volume
2,141,771 shares
Average Trading Volume
3,430,100 shares
Today's Volume Vs. Average
62%
Short Selling Exact Sciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Exact Sciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

EXAS Short Interest Over Time

EXAS Days to Cover Over Time

EXAS Percentage of Float Shorted Over Time

Exact Sciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
10/31/202414,060,000 shares $969.16 million -9.5%N/A5.9 $68.93
10/15/202415,540,000 shares $1.09 billion +10.8%N/A6.4 $69.95
9/30/202414,030,000 shares $955.72 million -14.6%N/A5.4 $68.12
9/15/202416,420,000 shares $1.08 billion +13.2%N/A5.9 $65.54
8/31/202414,510,000 shares $895.12 million +5.0%N/A5.3 $61.69
8/15/202413,820,000 shares $808.06 million +1.7%N/A4.8 $58.47
7/31/202413,590,000 shares $620.79 million -2.8%N/A4.1 $45.68
7/15/202413,980,000 shares $657.76 million -1.6%N/A4.7 $47.05
6/30/202414,210,000 shares $600.37 million +50.4%N/A4.7 $42.25
6/15/20249,450,000 shares $395.77 million +7.6%N/A3 $41.88
5/31/20248,780,000 shares $399.05 million +3.3%N/A3 $45.45
5/15/20248,500,000 shares $453.39 million -4.3%N/A2.9 $53.34
4/30/20248,880,000 shares $527.03 million -10.2%N/A3.6 $59.35
4/15/20249,890,000 shares $646.31 million +56.0%N/A4.1 $65.35
3/31/20246,340,000 shares $437.84 million -2.8%N/A2.8 $69.06
3/15/20246,520,000 shares $376.27 million -7.4%N/A3.4 $57.71
2/29/20247,040,000 shares $405.01 million -3.2%N/A3.6 $57.53
2/15/20247,270,000 shares $444.12 million -0.3%N/A4 $61.09
1/31/20247,290,000 shares $476.77 million -4.1%N/A4.3 $65.40
1/15/20247,600,000 shares $510.11 million +1.3%N/A4.6 $67.12
12/31/20237,500,000 shares $554.85 million +5.8%N/A4.5 $73.98
12/15/20237,090,000 shares $467.23 million -3.5%N/A4.4 $65.90
11/30/20237,350,000 shares $470.40 million +0.8%N/A5.1 $64.00
11/15/20237,290,000 shares $460.14 million -3.7%N/A5.1 $63.12
10/31/20237,570,000 shares $466.24 million -7.3%N/A5.4 $61.59
10/15/20238,170,000 shares $533.26 million +7.8%N/A5.8 $65.27
9/30/20237,580,000 shares $517.11 million -11.7%N/A5.3 $68.22
9/15/20238,580,000 shares $657.91 million +0.4%N/A6.3 $76.68
8/31/20238,550,000 shares $715.38 million +1.9%N/A5.5 $83.67
8/15/20238,390,000 shares $721.71 million -2.9%N/A5.2 $86.02
7/31/20238,640,000 shares $842.75 million -4.4%N/A4.7 $97.54
7/15/20239,040,000 shares $875.70 million +1.8%N/A5.1 $96.87
6/30/20238,880,000 shares $833.83 million -13.0%N/A5 $93.90
6/15/202310,210,000 shares $953.51 million +8.9%N/A5.4 $93.39
5/31/20239,380,000 shares $765.22 million -4.4%N/A5 $81.58
5/15/20239,810,000 shares $793.92 million -11.7%N/A4.7 $80.93
4/30/202311,110,000 shares $711.82 million -3.2%N/A5.8 $64.07
4/15/202311,480,000 shares $766.75 million -2.7%N/A5.7 $66.79
3/31/202311,800,000 shares $800.16 million -4.7%N/A4.8 $67.81
3/15/202312,380,000 shares $796.78 million -5.3%N/A4.9 $64.36
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
2/28/202313,070,000 shares $814.65 million +18.2%N/A4.9 $62.33
2/15/202311,060,000 shares $731.51 million -7.0%N/A4.4 $66.14
1/31/202311,890,000 shares $802.81 million -7.5%N/A4.6 $67.52
1/15/202312,850,000 shares $886.14 million +11.8%N/A4.8 $68.96
12/30/202211,490,000 shares $568.87 million +15.1%N/A4.6 $49.51
12/15/20229,980,000 shares $445.21 million -1.4%N/A4.2 $44.61
11/30/202210,120,000 shares $454.89 million +2.0%N/A4.7 $44.95
11/15/20229,920,000 shares $439.26 million -2.6%N/A4.4 $44.28
10/31/202210,180,000 shares $354.06 million -4.1%N/A4.3 $34.78
10/15/202210,620,000 shares $322.32 million -9.2%N/A4.7 $30.35
9/30/202211,690,000 shares $379.81 million +4.2%N/A5.4 $32.49
9/15/202211,220,000 shares $458.79 million +14.0%N/A5.2 $40.89
8/31/20229,840,000 shares $349.81 million +4.5%N/A4.5 $35.55
8/15/20229,420,000 shares $416.74 million -2.9%N/A4.4 $44.24
7/31/20229,700,000 shares $437.47 million -9.7%N/A4.5 $45.10
7/15/202210,740,000 shares $503.71 million -3.1%N/A4.8 $46.90
6/30/202211,080,000 shares $436.44 million +1.3%N/A5 $39.39
6/15/202210,940,000 shares $423.27 million -5.2%N/A5 $38.69
5/31/202211,540,000 shares $574.81 million -14.6%N/A5.7 $49.81
5/15/202213,520,000 shares $706.96 million -0.5%N/A6.6 $52.29
4/30/202213,590,000 shares $748.13 million -4.2%N/A7.1 $55.05
4/15/202214,180,000 shares $987.07 million +3.1%N/A7.5 $69.61
3/31/202213,760,000 shares $962.10 million +1.8%N/A6.8 $69.92
3/15/202213,520,000 shares $778.21 million +5.0%N/A6.6 $57.56
2/28/202212,880,000 shares $1.01 billion +8.1%N/A6.2 $78.06
2/15/202211,920,000 shares $968.86 million -1.9%N/A5.6 $81.28
1/31/202212,150,000 shares $927.77 million +5.7%N/A6 $76.36
1/15/202211,500,000 shares $901.95 million +1.1%N/A5.7 $78.43
12/31/202111,370,000 shares $884.93 million -5.8%N/A6.6 $77.83
12/15/202112,070,000 shares $961.50 million -3.4%N/A7.5 $79.66
11/30/202112,500,000 shares $1.07 billion +4.2%N/A8.1 $85.37
11/15/202112,000,000 shares $1.08 billion +0.3%N/A8.3 $89.97
10/29/202111,960,000 shares $1.14 billion -6.2%N/A8.3 $95.22
10/15/202112,750,000 shares $1.26 billion +19.4%N/A9.2 $98.96
9/30/202110,680,000 shares $1.02 billion -1.6%N/A7.7 $95.45
9/15/202110,850,000 shares $1.14 billion +9.5%N/A8.3 $104.65
8/31/20219,910,000 shares $1.03 billion +6.0%N/A7.6 $104.38
8/13/20219,350,000 shares $868.99 million +3.7%N/A7 $92.94
7/30/20219,020,000 shares $972.72 million +1.5%N/A6.3 $107.84
7/15/20218,890,000 shares $989.99 million -4.7%N/A6.4 $111.36
6/30/20219,330,000 shares $1.16 billion -0.2%N/A6.6 $124.31
6/15/20219,350,000 shares $1.15 billion -0.6%N/A6.4 $122.57
5/28/20219,410,000 shares $1.04 billion +1.3%N/A6.3 $110.53
5/14/20219,290,000 shares $870.10 million -2.1%N/A5.8 $93.66
4/30/20219,490,000 shares $1.26 billion -2.5%N/A5.9 $133.02
4/15/20219,730,000 shares $1.24 billion +1.7%N/A6 $127.14
3/31/20219,570,000 shares $1.18 billion +8.1%N/A5.3 $123.65
3/15/20218,850,000 shares $1.14 billion +4.1%N/A4.9 $128.46
2/26/20218,500,000 shares $1.12 billion +1.0%N/A4.6 $131.30
2/12/20218,420,000 shares $1.24 billion -1.1%N/A4.7 $146.68
JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)

Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.

Get your free guide NOW before it's too late.
1/29/20218,510,000 shares $1.19 billion -9.0%N/A5.2 $139.55
1/15/20219,350,000 shares $1.38 billion -4.2%N/A4.6 $147.29
12/31/20209,760,000 shares $1.32 billion -7.7%N/A5.2 $135.40
12/15/202010,570,000 shares $1.37 billion -2.0%N/A4.9 $129.80
11/30/202010,780,000 shares $1.27 billion -8.5%N/A5 $118.19
11/15/202011,780,000 shares $1.45 billion +1.7%N/A5.5 $122.71
10/30/202011,580,000 shares $1.40 billion -9.7%N/A5.5 $120.51
10/15/202012,830,000 shares $1.33 billion -6.1%N/A7.4 $103.50
9/30/202013,660,000 shares $1.39 billion +8.2%N/A7.8 $101.95
9/15/202012,630,000 shares $966.07 million -4.1%N/A7.8 $76.49
8/31/202013,170,000 shares $991.57 million No ChangeN/A9.3 $75.29
8/14/202013,170,000 shares $1.12 billion +2.3%N/A10.1 $85.33
7/31/202012,870,000 shares $1.22 billion -2.9%N/A9.4 $94.75
7/15/202013,250,000 shares $1.23 billion -0.4%N/A9.3 $92.98
6/30/202013,300,000 shares $1.16 billion -6.9%N/A8.6 $86.94
6/15/202014,290,000 shares $1.27 billion +1.8%N/A8.5 $89.16
5/29/202014,040,000 shares $1.21 billion -4.0%N/A6.9 $85.88
5/15/202014,620,000 shares $1.26 billion +4.1%N/A5.9 $86.29
4/30/202014,040,000 shares $1.11 billion +0.8%N/A5.6 $78.98
4/15/202013,930,000 shares $930.80 million -4.1%N/A5.7 $66.82
3/31/202014,530,000 shares $1.10 billion +1.4%N/A5.4 $75.46
3/13/202014,328,900 shares $960.90 million -9.4%N/A4.1 $67.06
2/28/202015,820,000 shares $746.55 million +9.5%N/A6.7 $47.19
2/14/202014,450,000 shares $937.95 million -0.7%11.3%6.8 $64.91
1/31/202014,550,000 shares $1.18 billion -3.8%11.3%7.1 $80.76
1/15/202015,120,000 shares $1.43 billion +5.2%11.8%6.4 $94.83
12/31/201914,380,000 shares $1.29 billion +11.5%11.2%6.6 $89.57

EXAS Short Interest - Frequently Asked Questions

What is Exact Sciences' current short interest?

Short interest is the volume of Exact Sciences shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 14,060,000 shares of EXAS short. Learn More on Exact Sciences' current short interest.

What is a good short interest ratio for Exact Sciences?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. EXAS shares currently have a short interest ratio of 6.0. Learn More on Exact Sciences's short interest ratio.

Which institutional investors are shorting Exact Sciences?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Exact Sciences: Barclays PLC, Jane Street Group LLC, Wolverine Trading LLC, Walleye Trading LLC, Walleye Capital LLC, Crawford Fund Management LLC, BNP Paribas Financial Markets, Citigroup Inc., One River Asset Management LLC, LMR Partners LLP, Wolverine Asset Management LLC, Concourse Financial Group Securities Inc., and Cubist Systematic Strategies LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Exact Sciences' short interest increasing or decreasing?

Exact Sciences saw a decrease in short interest in October. As of October 31st, there was short interest totaling 14,060,000 shares, a decrease of 9.5% from the previous total of 15,540,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Exact Sciences' short interest compare to its competitors?

Here is how the short interest of companies compare to Exact Sciences: Charles River Laboratories International, Inc. (3.62%), Medpace Holdings, Inc. (4.31%), ICON Public Limited (1.32%), National Research Co. (2.27%), Alnylam Pharmaceuticals, Inc. (2.87%), Biogen Inc. (2.16%), United Therapeutics Co. (5.24%), Incyte Co. (3.90%), Neurocrine Biosciences, Inc. (2.45%), BioMarin Pharmaceutical Inc. (2.82%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks.

What does it mean to sell short Exact Sciences stock?

Short selling EXAS is an investing strategy that aims to generate trading profit from Exact Sciences as its price is falling. EXAS shares are trading down $1.22 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Exact Sciences?

A short squeeze for Exact Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of EXAS, which in turn drives the price of the stock up even further.

How often is Exact Sciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including EXAS, twice per month. The most recent reporting period available is October, 31 2024.




This page (NASDAQ:EXAS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners